• Skip to primary navigation
  • Skip to content
  • Skip to footer
  • Estudantes
    • Webmail
    • Moodle
    • Ensino à Distância
    • NetP@
    • Biblioteca
    • Escola Doutoral
    • Serviços Académicos
    • Trabalhar no IHMT
  • Staff
    • Webmail
    • Área de Docentes
    • Área de Não-Docentes

IHMT

Instituto de Higiene e Medicina Tropical

PortuguêsEnglishFrançaisDeutschEspañol

Universidade Nova de Lisboa

  • Ensino
    • Doutoramentos
    • Mestrados
    • Ensino à Distância
    • Cursos de Especialização
    • Cursos de Curta Duração
    • Apoio ao Desenvolvimento
  • Investigação
    • GHTM
  • Doenças Tropicais
    • Glossário
    • Consulta do Viajante
    • Museu
      • Peça do Mês
    • Vídeos
    • MosquitoWeb
  • Unidades de Ensino e de Investigação
  • 5º Congresso Nacional de Medicina Tropical
Home / Publicações / Mosquito Akirin as a potential antigen for malaria control

Mosquito Akirin as a potential antigen for malaria control

  • Autores: A, Costa M, Custodio, de la Fuente J, Domingos A, Moreno-Cid JA, Pinheiro-Silva R, Silveira H, Villar M
  • Ano de Publicação: 2014
  • Journal: Malaria Journal
  • Link: http://www.malariajournal.com/content/13/1/470

Background

The control of vector-borne diseases is important to improve human and animal health worldwide. Malaria is one of the world’s deadliest diseases and is caused by protozoan parasites of the genus Plasmodium, which are transmitted by Anopheles spp. mosquitoes. Recent evidences using Subolesin (SUB) and Akirin (AKR) vaccines showed a reduction in the survival and/or fertility of blood-sucking ectoparasite vectors and the infection with vector-borne pathogens. These experiments suggested the possibility of using AKR for malaria control.

Methods

The role of AKR on Plasmodium berghei infection and on the fitness and reproduction of the main malaria vector, Anopheles gambiae was characterized by evaluating the effect of akr gene knockdown or vaccination with recombinant mosquito AKR on parasite infection levels, fertility and mortality of female mosquitoes.

Results

Gene knockdown by RNA interference in mosquitoes suggested a role for akr in mosquito survival and fertility. Vaccination with recombinant Aedes albopictus AKR reduced parasite infection in mosquitoes fed on immunized mice when compared to controls.

Conclusions

These results showed that recombinant AKR could be used to develop vaccines for malaria control. If effective, AKR-based vaccines could be used to immunize wildlife reservoir hosts and/or humans to reduce the risk of pathogen transmission. However, these vaccines need to be evaluated under field conditions to characterize their effect on vector populations and pathogen infection and transmission.

Mosquito Akirin as a potential antigen for malaria control

  • Autores: A, Costa M, Custodio, de la Fuente J, Domingos A, Moreno-Cid JA, Pinheiro-Silva R, Silveira H, Villar M
  • Ano de Publicação: 2014
  • Journal: Malaria Journal
  • Link: http://www.malariajournal.com/content/13/1/470

Background

The control of vector-borne diseases is important to improve human and animal health worldwide. Malaria is one of the world’s deadliest diseases and is caused by protozoan parasites of the genus Plasmodium, which are transmitted by Anopheles spp. mosquitoes. Recent evidences using Subolesin (SUB) and Akirin (AKR) vaccines showed a reduction in the survival and/or fertility of blood-sucking ectoparasite vectors and the infection with vector-borne pathogens. These experiments suggested the possibility of using AKR for malaria control.

Methods

The role of AKR on Plasmodium berghei infection and on the fitness and reproduction of the main malaria vector, Anopheles gambiae was characterized by evaluating the effect of akr gene knockdown or vaccination with recombinant mosquito AKR on parasite infection levels, fertility and mortality of female mosquitoes.

Results

Gene knockdown by RNA interference in mosquitoes suggested a role for akr in mosquito survival and fertility. Vaccination with recombinant Aedes albopictus AKR reduced parasite infection in mosquitoes fed on immunized mice when compared to controls.

Conclusions

These results showed that recombinant AKR could be used to develop vaccines for malaria control. If effective, AKR-based vaccines could be used to immunize wildlife reservoir hosts and/or humans to reduce the risk of pathogen transmission. However, these vaccines need to be evaluated under field conditions to characterize their effect on vector populations and pathogen infection and transmission.

Footer

  • Sobre o IHMT
  • Organização
  • Docentes e Investigadores
  • Serviços Académicos
  • Recursos Humanos
  • Trabalhar no IHMT
  • Instrumentos de Gestão
  • Associação de Alunos e Amigos
  • Parcerias
  • Biblioteca
  • Biobanco GHTM-IHMT – Biotropical Resources
  • Ensino
  • Investigação
  • Cooperação e Desenvolvimento
  • Qualidade

Contactos

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

Contactos dos Serviços

Marcação de consultas:
+351 213 652 630/90
+351 213 627 553
medicina.viagens@ihmt.unl.pt

Subscrever newsletter

Follow us

  • Facebook
  • LinkedIn
  • YouTube
© Copyright 2021 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok